Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas
about
The aggressive peripheral T-cell lymphomas: 2013Cutaneous T-cell lymphoma: 2014 update on diagnosis, risk-stratification, and managementT-cell lymphomas, a challenging disease: types, treatments, and future.Characterization and identification of PARM-1 as a new potential oncogene.The heterogeneous landscape of ALK negative ALCL.IRF4/MUM1 expression is associated with poor survival outcomes in patients with peripheral T-cell lymphoma.Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencingGenetic susceptibility variants for chronic lymphocytic leukemia.Prediction and evaluation of protein farnesyltransferase inhibition by commercial drugs.ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes.Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas.Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsiesPathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified.Gene expression profiling identifies IRF4-associated molecular signatures in hematological malignanciesExpression of the chemokine receptor gene, CCR8, is associated With DUSP22 rearrangements in anaplastic large cell lymphomaThe oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma.Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management.Genetics of anaplastic large cell lymphomaMorphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 RearrangementsCD1d-restricted peripheral T cell lymphoma in mice and humans.Adult systemic anaplastic large-cell lymphoma: recommendations for diagnosis and managementPathobiology of T-cell and NK-cell lymphomas.MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphomaNew developments in the pathology of malignant lymphoma: a review of the literature published from August to December 2008.Recent advances in bone marrow biopsy pathology.IRF4: Immunity. Malignancy! Therapy?Molecular alterations and tumor suppressive function of the DUSP22 (Dual Specificity Phosphatase 22) gene in peripheral T-cell lymphoma subtypes.Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management.The aggressive peripheral T-cell lymphomas: 2012 update on diagnosis, risk stratification, and management.Advances in understanding the pathogenesis of systemic anaplastic large cell lymphomas.LMP1 signaling pathway activates IRF4 in latent EBV infection and a positive circuit between PI3K and Src is required.How I manage peripheral T-cell lymphoma, not otherwise specified and angioimmunoblastic T-cell lymphoma: current practice and a glimpse into the future.Recurrent Cytogenetic Abnormalities in Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia.Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides.Interferon regulatory factor 4 is activated through c-Src-mediated tyrosine phosphorylation in virus-transformed cells.Primary cutaneous anaplastic large cell lymphoma.Genetic alterations in systemic nodal and extranodal non-cutaneous lymphomas derived from mature T cells and natural killer cells.Clinical and prognostic differences between ALK-negative anaplastic large cell lymphoma and peripheral T cell lymphoma, not otherwise specified: a single institution experience.The aggressive peripheral T-cell lymphomas: 2017.The IRF family of transcription factors: Inception, impact and implications in oncogenesis.
P2860
Q27003257-C2A86AC9-761D-4D4F-A934-0C1B9B98FA0EQ27024076-E1BF7D4D-FE3E-4F8B-8FEF-8AACDCADDA91Q30244553-2745428B-702D-4798-8892-89A25AD38454Q30543401-19DC2D6E-CA74-4F6C-BBCD-632FCE40DA3CQ33567012-6C9BEB9D-9466-49EE-92D4-DA9571C6CA4AQ33702340-B76DD8A1-C3E5-4BDA-B286-4A60D4199887Q33732485-94E81B2C-897D-4140-9A38-F305A01D6B02Q33780771-9F49B23E-B73C-40C6-AAA2-ED236DCDCBD2Q33840802-9A990222-C768-47A2-A8E0-EB5FDCD44CEDQ34106853-8E90D50F-D9CC-40B3-B0A0-39D94F7F3F55Q34362370-034B092A-8AF7-4FF5-A978-A17C6064627CQ35065024-0906A3A6-32D4-4D37-8223-D3587BD1CBC9Q35104047-7F224E90-86A7-4E20-9751-4AFC209E5FD3Q35245799-E0E3132A-C6FF-496E-8FFE-DEF98443A37CQ35593893-49C8CFFF-6E33-4EF2-8947-B6994A7405EAQ35607281-FE216D64-491D-466C-928D-BC83C8217205Q36470196-76848A9F-BD46-4608-8563-7CE045A3B6DCQ36519797-BBEE7821-4E5A-4BC2-8E5C-AEA16AB80EC6Q36807290-8C28F2ED-C623-4AFA-89CB-9769025EE0B8Q36863110-55074242-A44E-46F4-8EFE-171DF3D3950EQ36926529-8F11D1BB-9C3B-41ED-83E6-9EB530CDFE32Q37033993-D64021F6-8D56-4BEE-B52C-4924BD38ACF7Q37186470-7BFD3510-1F91-4311-8B02-9088C9CD9FB9Q37269044-DD805DB5-8E62-480D-994C-EE877CC2EDD6Q37301282-A11EF97A-6DF8-49D0-9BA0-228484A4E381Q37454043-EE9B4713-446B-4437-9BA5-2624C5187848Q37708848-8DEC7C81-DD07-4144-9762-03BC4CF43A2FQ37944565-988F61DB-6EEE-4E9B-A557-50AC69CFD0E7Q38003075-5E12A6F1-0512-4811-B250-09326769BA0CQ38307616-D1FD4B4B-758A-4D6E-A1E1-F5328398571EQ38732564-05AEBDC6-11EC-427D-A096-9C7D591A9F7CQ38782072-BC1FF4FE-4F24-4AC6-9397-4D0850237D38Q38788221-6E3A7C5E-8340-4B2E-BB6B-E5DE6C5ADCEDQ38813983-49547BCF-5191-40E9-8602-618C1E9323A2Q39134387-3251C06B-0D41-406C-91A9-224B0AA04DFCQ39200210-1B89BEBD-9890-43A6-958D-972FDE42C3FAQ39620024-61297130-9C04-4721-ABB5-5152F2270B1BQ39746344-F2F99A18-55C8-45F3-BD0B-550BE7F9C133Q40197352-512750EF-966C-470F-8BFE-5B548C018707Q41888239-5DD1A7E1-E1AC-4F52-B36E-D7F5460F2317
P2860
Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas
@en
Recurrent translocations invol ...... n peripheral T-cell lymphomas.
@nl
type
label
Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas
@en
Recurrent translocations invol ...... n peripheral T-cell lymphomas.
@nl
prefLabel
Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas
@en
Recurrent translocations invol ...... n peripheral T-cell lymphomas.
@nl
P2093
P2860
P356
P1433
P1476
Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas
@en
P2093
E D Remstein
L A Erickson
P J Kurtin
P2860
P2888
P304
P356
10.1038/LEU.2008.320
P577
2008-11-06T00:00:00Z